Search Results

search

Search Filters

Tag
Pharmaceutical
Logo_AdipoPharma_V1.png
French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance
November 11, 2024 12:43 ET | AdipoPharma
STRASBOURG, France, Nov. 11, 2024 (GLOBE NEWSWIRE) -- AdipoPharma, a biotech company headquartered in France with offices in the US and Belgium developing a novel and promising Type 2 diabetes drug,...
EvolveImmune Logo.jpg
EvolveImmune Therapeutics Presents New Preclinical and Translational Data Highlighting Pipeline Progress for EVOLVE T Cell Engager Platform at 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
November 11, 2024 07:00 ET | EvolveImmune
Poster Presentations Spotlight Differentiated Therapeutic Profile and Precision Therapeutic Strategy for Lead Development Candidate EVOLVE104 as Program Advances Toward Clinic for Solid Tumors EVOLVE...
medac_Logo_Claim_PAN_U_1709827247729.jpg
Vielversprechende Kooperation zwischen medac und chiron zur Entwicklung von Organ-on-chip Technologie
November 07, 2024 09:00 ET | medac Gesellschaft für klinische Spezialpräparate mbH
WEDEL, Deutschland, Nov. 07, 2024 (GLOBE NEWSWIRE) -- In der Arzneimittelentwicklung sind Tierversuche zurzeit noch ein regulatorisch verankerter Bestandteil, gleichzeitig schreitet die Entwicklung...
medac_Logo_Claim_PAN_U_1709827247729.jpg
Promising cooperation between medac and chiron for the development of organ-on chip technology
November 07, 2024 09:00 ET | medac Gesellschaft für klinische Spezialpräparate mbH
WEDEL, Germany, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Testing new substances in animals is a regulatory cornerstone of drug development. At the same time, the development of animal free testing methods...
Lifecore-Corporate_Logo_2C.png
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024
November 07, 2024 07:00 ET | Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Synox Logo.jpg
SynOx Therapeutics Further Strengthens Executive Team with Appointments of U.S.-Based Chief Medical Officer and Chief Commercial Officer
November 07, 2024 07:00 ET | SynOx Therapeutics Limited
Additions of Elyse Seltzer, M.D., as CMO and Robert Francomano as CCO Strengthen Company’s Presence in the U.S. Seasoned Team to Drive Forward Pivotal Phase 3 Trial of Emactuzumab in Patients...
Prognomiq_Logo_RGB.jpg
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
November 05, 2024 09:00 ET | PrognomiQ
PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform
Logo-OLON+payoff.jpg
Olon ist bereit für die Produktion in der neuen Anlage für hoch starke Wirkstoffe
November 04, 2024 05:00 ET | Olon SpA
MAILAND, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Olon, ein Arzneimittelhersteller und globales CDMO-Unternehmen, bestätigt den Zeitplan für den Bau seiner neuen Produktionsanlage für hoch starke...
Logo-OLON+payoff.jpg
Olon est prête à lancer la production dans sa nouvelle installation dédiée aux composés ultra-puissants
November 04, 2024 05:00 ET | Olon SpA
MILAN, 04 nov. 2024 (GLOBE NEWSWIRE) -- Olon, fournisseur d’API et acteur mondial dans le domaine des CDMO, confirme le respect du calendrier de construction de sa nouvelle installation dédiée aux...
Logo-OLON+payoff.jpg
Olon is ready to host productions in the new facility dedicated to ultra-potent compounds
November 04, 2024 05:00 ET | Olon SpA
Olon is ready to host productions in the new facility dedicated to ultra-potent compounds